Aircraft Medical is specialist developer and producer of high quality medical devices focussed on the needs of anaesthesia and critical care professionals. The company is a leader in the rapidly emerging video laryngoscope market with their McGRATH® Series 5 achieving marketing penetration across 35 countries globally.
Following initial profitability in 2009, the company demonstrated global market traction backed by product patent protection and a management team focused on industry leading development and design, the Par Syndicate invested in April 2011.
Medtronic plc (NYSE:MDT) acquired Aircraft Medical in order to support the company’s therapy innovation strategy. The $110 million acquisition in November 2015 generated a c. 3.8x cash on cash return for Par investors.
What they said
Steve Blazejewski, senior vice president at Medtronic commented "Aircraft Medical’s offerings complement our portfolio, helping us further our commitment to reducing incidents and potential complications from respiratory compromise globally. The company’s laryngoscopes will play an important role in our airways portfolio as we develop and provide meaningful innovations that improve patient outcomes."